v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenue $ 279,827 $ 209,993
Cost of revenue 67,700 44,938
Gross profit 212,127 165,055
Operating expenses:    
Selling and marketing 123,527 91,858
Research and development 69,349 56,097
General and administrative 43,001 39,192
Total operating expenses 235,877 187,147
Operating loss (23,750) (22,092)
Other income:    
Other (expense) income (664) 68
Interest income 9,259 9,546
Total other income, net 8,595 9,614
Loss before income taxes (15,155) (12,478)
(Benefit) provision for income taxes (1,066) 404
Net loss (14,089) (12,882)
Comprehensive loss $ (14,089) $ (12,882)
Net loss per share attributable to Series A and Series B common stockholders, basic (in dollars per share) $ (0.05) $ (0.05)
Net loss per share attributable to Series A and Series B common stockholders, diluted (in dollars per share) $ (0.05) $ (0.05)
Weighted average common shares outstanding, basic (in shares) 274,198,213 261,332,411
Weighted average common shares outstanding, diluted (in shares) 274,198,213 261,332,411